Skip to main content
SpringerLink
Log in

Bariatric Surgery in the Therapy of Type 2 Diabetes Mellitus

  • Reference work entry
  • First Online:
Principles of Diabetes Mellitus

  • 3478 Accesses

Abstract

Surgical procedures that alter food intake and change the pathway of food have been shown to be effective treatment for type 2 diabetes. It appears that there multiple mechanisms are involved and that the operations do more than just reduce caloric intake. Beta cell response improves, as does insulin sensitivity. Different surgical procedures have varying degrees of efficacy with operations that reduce gastric capacity and divert the biliary stream having the greatest effectiveness. In this chapter we review the development of metabolic procedures, discuss their effectiveness, and explain future directions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yu J, Zhou X, Li L, Li S, Tan J, Li Y, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25(1):143–58.

    Article  PubMed  Google Scholar 

  2. Wang MC, Guo XH, Zhang YW, Zhang YL, Zhang HH, Zhang YC. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with Type 2 diabetes: a meta-analysis of randomized controlled trials. Am Surg. 2015;81(2):166–71.

    PubMed  Google Scholar 

  3. Brethauer SA, Aminian A, Romero-Talamas H, Batayyah E, Mackey J, Kennedy L, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 36–7.

    PubMed  PubMed Central  Google Scholar 

  4. Nergard BJ, Lindqvist A, Gislason HG, Groop L, Ekelund M, Wierup N, et al. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass. Surg Obes Relat Dis. 2015.

    Google Scholar 

  5. Lindegaard KK, Jorgensen NB, Just R, Heegaard PM, Madsbad S. Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes. Diabetol Metab Syndr. 2015;7:12.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab. 2015;19(5):563–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev. 2008;60(4):470–512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dotson CD, Vigues S, Steinle NI, Munger SD. T1R and T2R receptors: the modulation of incretin hormones and potential targets for the treatment of type 2 diabetes mellitus. Curr Opin Investig Drugs. 2010;11(4):447–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of ‘taste’ in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes. 2008;15(1):73–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41.

    Article  CAS  PubMed  Google Scholar 

  11. Mendis S. Global status report on noncommunicable diseases 2014: WHO; 2014. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1

  12. Sims EAH. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50(12):1499–504.

    Article  CAS  PubMed  Google Scholar 

  13. Thorell A, Hagstrom-Toft E. Treatment of diabetes prior to and after bariatric surgery. J Diabetes Sci Technol. 2012;6(5):1226–32.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Alharbi NS, Almutari R, Jones S, Al-Daghri N, Khunti K, de Lusignan S. Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: systematic review and meta-analysis. Diabetes Res Clin Pract. 2014;106(2):e30–3.

    Article  PubMed  Google Scholar 

  15. Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64–91.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Santry HP, Gillen DL, Lauderdale DS. TRends in bariatric surgical procedures. JAMA. 2005;294(15):1909–17.

    Article  CAS  PubMed  Google Scholar 

  18. ASMBS. Estimate of Bariatric Surgery Numbers, 2011–2014 2015. Available from: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers

  19. Leyton O. Diabetes. A recoverable disease. Lancet. 1926;207(5356):885 p.

    Article  Google Scholar 

  20. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50. discussion 50–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  CAS  PubMed  Google Scholar 

  23. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353(3):249–54.

    Article  CAS  PubMed  Google Scholar 

  24. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Suter M, Calmes JM, Paroz A, Giusti V. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg. 2006;16(7):829–35.

    Article  CAS  PubMed  Google Scholar 

  26. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.e5.

    Article  PubMed  Google Scholar 

  27. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  CAS  PubMed  Google Scholar 

  28. Fischer L, Hildebrandt C, Bruckner T, Kenngott H, Linke GR, Gehrig T, et al. Excessive weight loss after sleeve gastrectomy: a systematic review. Obes Surg. 2012;22(5):721–31.

    Article  PubMed  Google Scholar 

  29. Stefater MA, Wilson-Perez HE, Chambers AP, Sandoval DA, Seeley RJ. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595–622.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes – 3-year outcomes. N Engl J Med. 2014;370(21):2002–13.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. Ann Surg. 2006;244(4):611–9.

    PubMed  PubMed Central  Google Scholar 

  32. Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. J Gastrointest Surg. 2010;14(2):211–20.

    Article  PubMed  Google Scholar 

  33. Dorman RB, Rasmus NF, al-Haddad BJ, Serrot FJ, Slusarek BM, Sampson BK, et al. Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery. 2012;152(4):758–65, discussion 65–7.

    Article  PubMed  Google Scholar 

  34. Nelson DW, Blair KS, Martin MJ. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg. 2012;147(9):847–54.

    Article  PubMed  Google Scholar 

  35. Chikunguwo SM, Wolfe LG, Dodson P, Meador JG, Baugh N, Clore JN, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9.

    Article  PubMed  Google Scholar 

  36. Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, Haneuse S, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23(1):93–102.

    Article  PubMed  PubMed Central  Google Scholar 

  37. DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249–53.

    Article  PubMed  Google Scholar 

  38. Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.

    Article  PubMed  Google Scholar 

  39. Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.

    Article  CAS  PubMed  Google Scholar 

  40. Campos JM, Lins DC, Silva LB, Araujo-Junior JG, Zeve JL, Ferraz AA. Metabolic surgery, weight regain and diabetes re-emergence. Arq Bras Cir Dig. 2013;26 Suppl 1:57–62.

    Article  PubMed  Google Scholar 

  41. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Kashyap SR, Bhatt DL, Schauer PR, Investigators S. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab. 2010;12:452–4. England.

    Article  PubMed  Google Scholar 

  43. McLaughlin T, Peck M, Holst J, Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab. 2010;95(4):1851–5.

    Article  CAS  PubMed  Google Scholar 

  44. Mathavan VK, Arregui M, Davis C, Singh K, Patel A, Meacham J. Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc. 2010;24(10):2547–55.

    Article  PubMed  Google Scholar 

  45. Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC. Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis. 2013;9(1):26–31.

    Article  PubMed  Google Scholar 

  46. Roslin MS, Dudiy Y, Brownlee A, Weiskopf J, Shah P. Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch. Surg Endosc. 2014;28(1):91–9.

    Article  PubMed  Google Scholar 

  47. Mingrone G, Rosa G, Di Rocco P, Manco M, Capristo E, Castagneto M, et al. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord. 2002;26(9):1165–72.

    Article  CAS  PubMed  Google Scholar 

  48. Strain GW, Gagner M, Inabnet WB, Dakin G, Pomp A. Comparison of effects of gastric bypass and biliopancreatic diversion with duodenal switch on weight loss and body composition 1–2 years after surgery. Surg Obes Relat Dis. 2007;3(1):31–6.

    Article  PubMed  Google Scholar 

  49. Frenken M, Cho EY, Karcz WK, Grueneberger J, Kuesters S. Improvement of type 2 diabetes mellitus in obese and non-obese patients after the duodenal switch operation. J Obes. 2011;2011:860169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Spector D, Shikora S. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus. Int J Clin Pract Suppl. 2010;166:53–8.

    Article  Google Scholar 

  51. Camerini G, Marinari GM, Scopinaro N. A new approach to the fashioning of the gastroenteroanastomosis in laparoscopic standard biliopancreatic diversion. Surg Laparosc Endosc Percutan Tech. 2003;13(3):165–7.

    Article  PubMed  Google Scholar 

  52. Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8.

    Article  PubMed  Google Scholar 

  53. Sanchez-Pernaute A, Herrera MA, Perez-Aguirre ME, Talavera P, Cabrerizo L, Matia P, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720–6.

    Article  PubMed  Google Scholar 

  54. Roslin MS, Gagner M, Goriparthi R, Mitzman B. The rationale for a duodenal switch as the primary surgical treatment of advanced type 2 diabetes mellitus and metabolic disease. Surg Obes Relat Dis. 2015;11(3):704–10.

    Article  PubMed  Google Scholar 

  55. Mahmoud AA, Elshazly SM. Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. PLoS One. 2014;9(9), e106993.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Benotti PN, Forse RA. The role of gastric surgery in the multidisciplinary management of severe obesity. Am J Surg. 1995;169(3):361–7.

    Article  CAS  PubMed  Google Scholar 

  57. Introducing SIPSS: Stomach Intestinal Pyloric Sparing Surgery – An Effective Modification fo Duodenal Switch (DS) [Internet]. 2014. Available from: http://2014.obesityweek.com/wp/uploads/2014/10/Wednesday-Abstracts.pdf

  58. Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, et al. Duodenal switch: long-term results. Obes Surg. 2007;17(11):1421–30.

    Article  PubMed  Google Scholar 

  59. DePaula AL, Macedo AL, Rassi N, Vencio S, Machado CA, Mota BR, et al. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc. 2008;22(12):2670–8.

    Article  CAS  PubMed  Google Scholar 

  60. Celik A, Ugale S, Ofluoglu H, Asci M, Celik BO, Vural E, et al. Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT). Obes Surg. 2015;25(7):1184–90.

    Article  PubMed  Google Scholar 

  61. Rohde U, Hedback N, Gluud LL, Vilsboll T, Knop FK. Effect of the EndoBarrier iGastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies. BMJ Open. 2013;3(9), e003417.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Rohde U, Federspiel CA, Vilmann P, Friis SU, Langholz E, Vilsboll T, et al. Premature explantation of an EndoBarrier gastrointestinal liner because of sleeve invagination. Endoscopy. 2015;47(Suppl 1 UCTN):E275–6.

    PubMed  Google Scholar 

  63. Neto MG. Duodenal mucosal resurfacing (DMR) – a new endoscopic treatment for Type 2 Diabetes (T2DM) – a safety and proof-of-principle cohort study International Federation for the Surgery of Obesity and Metabolic disorders2014. Available from: http://www.healio.com/endocrinology/obesity/news/online/%7Bc3434eaf-53ba-43da-b437-6bd486c39bf9%7D/duodenum-resurfacing-procedure-improved-type-2-diabetes-markersAvailable from: http://link.springer.com/article/10.1007%2Fs11695-014-1265-3

Download references

Conflicts of Interest

Mitchell Roslin is an educational consultant at Johnson & Johnson Incorporated, Covidien Limited and W.L. Gore & Associates and receives compensation from them. He is on the scientific advisory board at SurgiQuest and ValenTx and has stocks options in them.

Richie Goriparthi has no conflicts of interest to declare

Sarah Amalina has no conflicts of interest to declare

Angeliki Peristeri has no conflicts of interest to declare

Author information

Authors and Affiliations

  1. Department of Surgery, Lenox Hill Hospital, Hofstra Northwell School of Medicine, Northwell Health, 100 E 77th Street, New York, NY, 10075, USA

    Mitchell Roslin, Richie Goriparthi, Sarah Sabrudin & Angeliki Peristeri

Authors
  1. Mitchell Roslin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richie Goriparthi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarah Sabrudin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angeliki Peristeri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitchell Roslin .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Gerald J. Friedman Diabetes Institute, Lenox Hill Hospital, Hofstra Northwell School of Medicine, Northwell Health, New York, New York, USA

    Leonid Poretsky

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Roslin, M., Goriparthi, R., Sabrudin, S., Peristeri, A. (2017). Bariatric Surgery in the Therapy of Type 2 Diabetes Mellitus. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Cham. https://doi.org/10.1007/978-3-319-18741-9_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18741-9_55

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18740-2

  • Online ISBN: 978-3-319-18741-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation